2 Minute Medicine Rewind May 12 – May 19, 2014
Image: PD In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past ...
Image: PD In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past ...
Image: PD 1. When paired with statin therapy, evolocumab greatly reduced patient low-density lipoprotein cholesterol (LDL-C) levels compared to placebo ...
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
Image: PD 1. From an N-of-1, placebo-controlled, double-blinded crossover trial, no statistically significant difference was found in myalgia between statin ...
Image: PD 1. A mid-intensity statin plus ezetimibe lowered LDL-C more than high-intensity statin monotherapy in patients with either atherosclerotic ...
Image: PD 1. New clinical guidelines from the American College of Cardiology (ACC) and the American Heart Association (AHA) recommend ...
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
1. Statin therapy reduces the risk of coronary events in patients with known coronary heart disease and low-density lipoprotein levels ...
Image: CC 3.0/WikiCommons 1. There is a genome-wide significant locus for infantile hypertrophic pyloric stenosis IHPS on chromosome 11q in the ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.